Aurora Cannabis (ACB) EBITDA Margin Growth (3y) (2020 - 2025)
Aurora Cannabis (ACB) EBITDA Margin Growth (3y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 1,129.00 |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 2.00 |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 59.00 |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | -1,031.00 |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -925.00 |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | -46.00 |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 6,666.00 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Aurora Cannabis | 243.01 Mn | 170.70 Mn | 25.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2,127.00 |
| Sep 30, 2025 | 11,365.00 |
| Jun 30, 2025 | 11,835.00 |
| Mar 31, 2025 | 3,817.00 |
| Dec 31, 2024 | 12,280.00 |
| Sep 30, 2024 | 1,878.00 |
| Jun 30, 2024 | -1,081.00 |
| Mar 31, 2024 | 26,380.00 |
| Dec 31, 2023 | 8,045.00 |
| Sep 30, 2023 | 8,379.00 |
| Jun 30, 2023 | -34,111.00 |
| Dec 31, 2022 | -14,234.00 |
| Sep 30, 2022 | -16,203.00 |
| Jun 30, 2022 | -53,568.00 |
| Mar 31, 2022 | -7,600.00 |
| Dec 31, 2021 | -21,681.00 |
| Sep 30, 2021 | -39,714.00 |
| Jun 30, 2021 | -15,994.00 |
| Mar 31, 2021 | -6,738.00 |
| Dec 31, 2020 | 6,775.00 |